AGM Statement

Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc


 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 


 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO




 


Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com



 


Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers




 


Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie


  


Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons


 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Craneware (CRW)
UK 100

Latest directors dealings